Coffee consumption is not associated with prevalent subclinical cardiovascular disease (CVD) or the risk of CVD events, in nonalcoholic fatty liver disease: results from the Multi-Ethnic Study of Atherosclerosis

BACKGROUND: Atherosclerosis and its clinical sequelae represent the leading cause of mortality among patients with nonalcoholic fatty liver disease (NAFLD). While epidemiologic data support the hepatoprotective benefits of coffee in NAFLD, whether coffee improves NAFLD-associated CVD risk is unknown...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Metabolism
Main Authors: Simon, Tracey G., Perez Trejo, Maria Esther, Zeb, Irfan, Frazier-Wood, Alexis C., McClelland, Robyn L, Chung, Raymond T., Budoff, Matthew J.
Formáid: Artigo
Teanga:Inglês
Foilsithe: 2017
Ábhair:
Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5657519/
https://ncbi.nlm.nih.gov/pubmed/28964324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.metabol.2017.06.007
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla